Rite Aid (RADCQ)
(Delayed Data from OTC)
$0.04 USD
-0.01 (-20.00%)
Updated Aug 30, 2024 03:51 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RADCQ 0.04 -0.01(-20.00%)
Will RADCQ be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RADCQ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RADCQ
Zacks Industry Outlook Highlights CVS Health, Herbalife, Rite Aid and Amazon
3 Retail Pharmacy & Drugstore Stocks to Watch Amid Industry Headwinds
RADCQ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Walgreens Boots Alliance (WBA) Tops Q1 Earnings and Revenue Estimates
Costco (COST) Q1 Earnings and Revenues Beat Estimates
Other News for RADCQ
Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine
Healthcare bankruptcies slow after peaking in 2023: report
Rite Aid Announces Availability of Flu and RSV Vaccine Appointments at All Locations
Drugstores tinker with new looks as their usual way of doing business faces challenges
3 Cybersecurity Stocks That Could Be Multibaggers in the Making: July Edition